CompletedNCT06476509
A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
Medication studyAges 18–45ChinaDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- ShanghaiSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: May 30, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Vigonvita Life Sciences
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- China
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT06476509
- Official title
Show the full official title
A Non-Randomized, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of LV232 Capsule Assessing Serotonin Transporter Occupancy in the Healthy Adult Brain Using 11C-DASB Positron Emission Tomography (PET)
Get this study by email
Recruitment & locations
CompletedShanghai
Questions about this study
Who is behind this study?
The study sponsor is Vigonvita Life Sciences.
Did this study involve medication?
Yes. The study involved medication, including LV232 40mg, Escitalopram 20 mg, LV232 60mg and LV232 20mg.
Who was this study for?
Listed age limits: 18 years to 45 years.
Want to explore more studies?
Explore studiesRelated studies
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive Disorder